Evidence map›Paper›PMID 23627894›Full record

ArticleStem cells and development2013

Reprogramming adult human dermal fibroblasts to islet-like cells by epigenetic modification coupled to transcription factor modulation.

Liora S Katz, Elizabeth Geras-Raaka, Marvin C Gershengorn

Open access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Liver to Pancreas Transdifferentiation.Current diabetes reports · 2019
    Review
  7. Article
  8. Epigenetic Control of Endocrine Pancreas DifferentiationFrontiers in cell and developmental biology · 2018
    Review
  9. Article
  10. Computational methods for direct cell conversion.Cell cycle (Georgetown, Tex.) · 2016
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liora S KatzLaboratory of Endocrinology and Receptor Biology, NIDDK, NIH, Bethesda, Maryland 20892-8029, USA.
Elizabeth Geras-Raaka
Marvin C Gershengorn
National Institutes of Health · US

Funding

Study Of Factors That Induce Differentiation Of Pancreatic Precursor CellsZ01DK011007 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI GERSHENGORN, MARVIN C · 2002 to 2008
$1.1M
NIDDK NIH HHS Z01 DK011007
6 · The paper itself

Abstract

In this article, we describe novel conditions for culture, expansion, and transdifferentiation of primary human dermal fibroblasts (hDFs) to induce expression of transcription factors (TFs) and hormones characteristic of the islets of Langerhans. We show that histones associated with the insulin gene are hyperacetylated and that insulin gene DNA is less methylated in islet cells compared to cells that do not express insulin. Using two compounds that alter the epigenetic signature of cells, romidepsin (Romi), a histone deacetylase inhibitor, and 5-Azacytidine (5-AzC), a chemical analogue of cytidine that cannot be methylated, we show that hDFs exhibit a distinctive regulation of expression of TFs involved in islet development as well as of induction of glucagon and insulin. Overexpression of Pdx1, a TF important for islet differentiation, and silencing of musculoaponeurotic fibrosarcoma oncogene homolog B, a TF that is expressed in mature glucagon-producing cells, result in induction of insulin to a higher level compared to Romi and 5-AzC alone. The cells obtained from this protocol exhibit glucose-stimulated insulin secretion and lower blood glucose levels of diabetic mice. These data show that fully differentiated nonislet-derived cells could be made to transdifferentiate to islet-like cells and that combining epigenetic modulation with TF modulation leads to enhanced insulin expression.

Indexed as

AcetylationAnimalsAzacitidineBlood GlucoseCell- and Tissue-Based TherapyCell TransdifferentiationCellular ReprogrammingDepsipeptidesDiabetes Mellitus, Type 1DNA MethylationFibroblastsGlucagonHistone Deacetylase InhibitorsHistonesHomeodomain ProteinsHormonesAzacitidineBlood GlucoseDepsipeptidesGlucagonHistone Deacetylase InhibitorsHistonesHomeodomain ProteinsHormonesInsulinMaf Transcription Factorspancreatic and duodenal homeobox 1 proteinromidepsinTrans-Activators

Identifiers

PMID23627894
PMCPMC3760074
OpenAlexW2081544138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.